
Investor
Inevitable Ventures
- Biotech
- Energy
HQ: San Francisco
Overview
Early-stage fund focused on frontier-tech themes including climate and biotech. SF HQ.
Part of the San Francisco ecosystem
Related
Cantos VenturesProvides initial capital and ongoing counsel to founders building advanced technologies, manufactured goods, critical resources, and systems for abundance, resilience, and advantage.
Fifty YearsInvests in pre-seed and seed startups and helps form companies, supporting founders applying technology and breakthrough science to major global problems.
Refactor CapitalEarly-stage fund for foundational technology and biology. Founded by David Lee.
Roots of ProgressBuilds a philosophy and culture of progress, supporting progress-focused intellectuals and communities through training, networking, events, collaboration, and idea exchange.
SOSVInvests in deep tech startups at pre-seed and supports founders through programs, labs, offices, and events focused on human and planetary health.
South Park CommonsBuilds an early-stage founder program offering no-cost residency, exploration support, learning groups, and funding for founders deciding what to build next.
Starlight VenturesStarlight Ventures backs founders using science and technology to transform large physical markets. Its portfolio and thesis span space, climate, energy, biotech, advanced materials, and AI-enabled infrastructure, making it a strong addition to the frontier investor set despite not being a single-sector fund.
8VCBuilds and invests in technology companies, partnering with entrepreneurs to develop platforms addressing areas such as healthcare, zero-emission aircraft, privacy enforcement, and urban tunneling.
Also CapitalInvests early in founders tackling hard problems, helping portfolio companies recruit initial teams and prepare to raise follow-on capital from later investors.
ARCH Venture PartnersBuilds and backs science-based companies, investing flexibly in portfolio businesses founded around technologies intended to affect human health and disease.
General InnovationProvides investment capital through General Innovation Capital Partners to support companies developing new products, commercial research, business services, and operations.
IndieBioProvides onsite biolabs and pre-seed investment for scientists launching startups across biotech, food, agriculture, industrial decarbonization, AI, therapeutics, and diagnostics.